News Cello Health acquired for £182m by private equity firm Cello Health has been acquired by Arsenal Capital Partners, a private equity firm investing in healthcare and industrials companies.
News FDA names a new CDER director, choosing a biotech vet The FDA has rounded out its senior leadership by naming biopharma industry executive George Tidmarsh to the role of CDER director.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face